ZomedicaZOM
About: Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
Employees: 144
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0.03% less ownership
Funds ownership: 8.89% [Q1] → 8.86% (-0.03%) [Q2]
0% less capital invested
Capital invested by funds: $12.3M [Q1] → $12.3M (-$12.8K) [Q2]
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
1% less funds holding
Funds holding: 96 [Q1] → 95 (-1) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for ZOM.